Shaily Engineering Plastics Limited — Investor Meet, 20-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Shaily Engineering Plastics reported strong Q3 FY'26 results: Revenue up 27% to INR 251 Cr, EBITDA up 43% to INR 66 Cr (26.5% margin), PAT up 48% to INR 37 Cr. Healthcare revenue soared 139% to INR 104 Cr, now 42% of total, driving overall growth.

Company plans a new INR 300-350 Cr pen/auto-injector facility in Abu Dhabi (75M units/year) by Q4 FY'28, boosting total capacity to 150M units. One new 25M pen line is in final qualification; another arrives by May '26. GLP-1 supplies have begun for Canada, Brazil, and India. Consumer electronics qualification nearing completion. Management is confident in healthcare's growth despite short-term delays.